Ampio Pharmaceuticals (AMPE) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free AMPE Stock Alerts $0.34 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAmpio Pharmaceuticals (NYSE:AMPE) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - April 21 at 2:16 AMAmpio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.comamericanbankingnews.com - April 13 at 2:24 AMAmpio Pharmaceuticals Received Audit Opinion with Going Concern Explanationfinance.yahoo.com - April 3 at 2:37 PMAmpio Pharmaceuticals Received Audit Opinion with Going Concern Explanationprnewswire.com - April 3 at 2:33 PMAMPE Stock Earnings: Ampio Pharmaceuticals Reported Results for Q4 2023investorplace.com - March 27 at 11:03 PMAmpio Pharmaceuticals Incmoney.usnews.com - March 26 at 2:08 PMAmpio Pharmaceuticals, Inc.: Ampio Announces Voluntary Delisting and SEC Deregistrationfinanznachrichten.de - March 26 at 9:08 AMUS Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readingsmsn.com - March 26 at 9:08 AMAmpio Announces Voluntary Delisting and SEC Deregistrationfinance.yahoo.com - March 25 at 5:28 PMAmpio Pharmaceuticals, Ironwood, Incannex among healthcare moversmsn.com - February 29 at 10:23 AMAmpio Pharmaceuticals, Inc.: Ampio Provides Update on Results from Pre-IND Enabling Studiesfinanznachrichten.de - February 15 at 9:58 AMAmpio Provides Update on Results from Pre-IND Enabling Studiesprnewswire.com - February 14 at 5:45 PMAmpio Pharmaceuticals Announces At-The-Market Stock Offeringmsn.com - January 26 at 9:38 AMSociedad Quimica Y Minera de Chile, Altice USA, Cingulate among premarket gainers' packseekingalpha.com - December 28 at 9:26 AMWhat's Going On With Ampio Pharmaceuticals Stock?msn.com - December 1 at 3:52 PMRedhill Biopharma, Ampio Pharmaceuticals among healthcare moversmsn.com - December 1 at 11:00 AMThinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly Groupbenzinga.com - November 30 at 10:10 AMAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201finance.yahoo.com - October 5 at 5:05 PMPresenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Nowfinance.yahoo.com - October 4 at 7:24 AMAmpio Pharmaceuticals to Present at the Emerging Growth Conferencefinance.yahoo.com - September 26 at 9:42 AMAmpio Pharmaceuticals (AMPE) Stock Tanks Today after Treatment Fails To Reach Primary Endpointthestreet.com - September 7 at 7:46 AMAmpio Pharmaceuticals announces 20-to-1 reverse stock splitseekingalpha.com - August 31 at 4:52 PMAmpio Pharmaceuticals Board Approves Reverse Stock Split - Quick Factsmarkets.businessinsider.com - August 31 at 7:04 AMAmpio Pharmaceuticals Announces Reverse Stock Splitfinance.yahoo.com - August 31 at 7:04 AMThinking about buying stock in Wavedancer, Urogen Pharma, Ampio Pharmaceuticals, Innoviz Technologies, or Rigetti Computing?benzinga.com - August 3 at 10:45 AM3 Biotech Stocks to Buy With Explosive Upside Potentialmsn.com - June 22 at 10:31 AMAMPE - Ampio Pharmaceuticals, Inc.finance.yahoo.com - June 3 at 7:37 AMAmpio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stockfinance.yahoo.com - May 26 at 4:56 PMAmpio stock jumps ~20% after CEO letter on drug program, reorganizationseekingalpha.com - April 18 at 1:43 PMAmpio Too Busy to Tell Investors Results of Eye Drug Studythestreet.com - April 3 at 7:17 PMWhy Ampio Pharmaceuticals (AMPE) Stock Is Plummeting Todaythestreet.com - February 9 at 6:24 PMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Ampio Pharmaceuticals, Inc.wsj.com - February 7 at 9:07 PMAmpio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standardsfinance.yahoo.com - December 27 at 6:25 PMAmpio Pharmaceuticals Announces NYSE American Removal of Trading Suspensionfinance.yahoo.com - November 17 at 6:33 PMAmpio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Splitfinance.yahoo.com - November 8 at 5:26 PMMONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firmstockhouse.com - October 16 at 2:54 PMAMPE DEADLINE TOMORROW: ROSEN, skilled investor counsel, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action - AMPEprnewswire.com - October 16 at 9:51 AMMONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firmbenzinga.com - October 12 at 7:24 PMROSEN, LEADING INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPEprnewswire.com - October 7 at 9:41 PMAmpio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedingsmarkets.businessinsider.com - October 4 at 9:12 AMNYSE American to Suspend Trading Immediately in Ampio Pharmaceuticals, Inc. (AMPE) and Commence Delisting Proceedingsbenzinga.com - October 3 at 6:32 PMCLASS ACTION UPDATE for AMPE, TWTR and CNTA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholdersbenzinga.com - September 30 at 3:58 PMROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPEprnewswire.com - September 28 at 5:13 PMAMPE Class Action Alert: If you Lost Money In Ampio Ampio Pharmaceuticals, Inc. (AMPE) Contact Robbins LLP for Information About Your Rightsbenzinga.com - September 23 at 5:20 AMAMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadlineprnewswire.com - September 22 at 6:11 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ampio Pharmaceuticals, Inc. – AMPEbenzinga.com - September 21 at 5:06 PMWhy ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarketbenzinga.com - September 21 at 7:30 AMAMPE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 17, 2022 in the Class Action Filed on Behalf of Ampio Pharmaceuticals, Inc. Shareholdersprnewswire.com - September 20 at 6:13 AMThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of WEBR, AMPE and HGENbenzinga.com - September 19 at 1:24 PMThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of AMPE, LTCH and SMRFbenzinga.com - September 16 at 6:43 PM Get Ampio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode April 20th? (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 AMPE Media Mentions By Week AMPE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPE News Sentiment▼0.000.46▲Average Medical News Sentiment AMPE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPE Articles This Week▼10▲AMPE Articles Average Week Get Ampio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aptevo Therapeutics News Today Athersys News Today China SXT Pharmaceuticals News Today Allarity Therapeutics News Today Aditxt News Today Bellerophon Therapeutics News Today Evofem Biosciences News Today SciSparc News Today Evelo Biosciences News Today Biodexa Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AMPE) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
